For millions of sufferers, there is nothing more debilitating than chronic back or joint pain. It can feel like a lifetime of misery.
But researchers led by University of Utah bioengineering assistant professor Robby Bowles have discovered a way to curb chronic pain by modulating genes that reduce tissue- and cell-damaging inflammation.
“This has applications for many inflammatory-driven diseases,” Bowles says. “It could be applied for arthritis or to therapeutic cells that are being delivered to inflammatory environments that need to be protected from inflammation.”
The team’s discovery was published in a new paper this month, “CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments,” in a special issue of Tissue Engineering. University of Utah bioengineering doctoral student, Niloofar Farhang, co-authored the study, which is a collaborative project between the University of Utah, Duke University and Washington University in St. Louis.
In chronic back pain, for example, slipped or herniated discs are a result of damaged tissue when inflammation causes cells to create molecules that break down tissue. Typically, inflammation is nature’s way of alerting the immune system to repair tissue or tackle infection. But chronic inflammation can instead lead to tissue degeneration and pain.
Bowles’ team is using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) system — new technology of modifying human genetics — to stop cell death and keep the cells from producing molecules that damage tissue and result in chronic pain. But it doesn’t do this by editing or replacing genes, which is what CRISPR tools are typically used for. Instead, it modulates the way genes turn on and off in order to protect cells from inflammation and thus breaking down tissue.
“So they won’t respond to inflammation. It disrupts this chronic inflammation pattern that leads to tissue degeneration and pain,” Bowles says. “We’re not changing what is in your genetic code. We’re altering what is expressed. Normally, cells do this themselves, but we are taking engineering control over these cells to tell them what to turn on and turn off.”
Now that researchers know they can do this, doctors will be able to modify the genes via an injection directly to the affected area and delay the degeneration of tissue. In the case of back pain, a patient may get a discectomy to remove part of a herniated disc to relieve the pain, but tissue near the spinal cord may continue to breakdown, leading to future pain. This method could stave off additional surgeries by stopping the tissue damage.
“The hope is that this stops degeneration in its tracks, and the patient could avoid any future surgeries,” Bowles says. “But it’s patient to patient. Some might still need surgery, but it could delay it.”
So far, the team has developed a virus that can deliver the gene therapy and has filed a patent on the system. They hope to proceed to human trials after collecting initial data, but Bowles believes it could be about 10 years before this method is used in patients.
The Latest on: Chronic pain
via Google News
The Latest on: Chronic pain
- More autonomy at work reduces the risk of low back painon January 23, 2020 at 3:02 pm
A team of psychologists has carried out a meta-analysis to identify psychosocial work factors that pose a risk for the development of chronic low back pain (CLBP). Their study clearly indicates that ...
- Abbott's Proclaim XR Neurostimulation Implant Device Said to Reduce Painon January 23, 2020 at 2:27 pm
Follow @BiologyFool At the 2020 North American Neuromodulation Society annual meeting, Abbott (NYSE:ABT) reported data from a clinical trial testing its Proclaim XR neurostimulation implant in ...
- Chronic pain patients plead for prescribing reformon January 23, 2020 at 2:17 pm
CONCORD - Chronic pain patients pleaded with a State Senate committee this week to eliminate “pre-determined” limits to getting prescription opioids they said threaten to leave them in unrelenting ...
- Abbott Announces Positive Results In Chronic Pain Studyon January 23, 2020 at 5:23 am
(RTTNews) - Abbott (ABT) announced positive results from a study, providing the scientific basis for the company's Proclaim XR recharge-free neurostimulation system for people living with chronic pain ...
- Medicare Will Cover Acupuncture for Chronic Back Painon January 22, 2020 at 2:55 pm
Medicare enrollees with chronic low back pain will be able to get up to 20 acupuncture treatments each year, under a new policy that the Centers for Medicare & Medicaid Services (CMS) announced ...
- Chronic idiopathic musculoskeletal pain diagnoses stem from pain history, not physical examon January 22, 2020 at 3:33 am
The key elements that guide the diagnosis of chronic idiopathic musculoskeletal pain do not primarily come from physical exam, but from the patient’s history of pain and the physician’s opinion, ...
- A Surprising Solution to Address Chronic Painon January 21, 2020 at 11:52 pm
(1) Not Speaking English You can’t learn French by “not speaking English.” What a ridiculous idea! But what about trying to solve chronic pain by focusing on “not being in pain?” Where is your ...
- Soin Neuroscience Develops A New Spinal Cord Stimulator to Treat Chronic Painon January 21, 2020 at 9:25 pm
DAYTON, Ohio, Jan. 22, 2020 /PRNewswire/ -- Soin Neuroscience, a biotechnology company based in Dayton, OH, has developed a new spinal cord stimulation device to treat chronic pain. The company has ...
- Scientists Target Link Between Chronic Pain, Cognitive Impairmentson January 20, 2020 at 10:56 pm
Chronic pain patients often suffer from impaired cognitive function as a side effect of their pain. That degradation isn’t addressed by pain-relief medications, some of which can even make the deficit ...
via Bing News